Table 4:

Morality rate and number of risk factors by eras and surgical procedure (n = 760)

Number of risk factors
Surgical procedure
Era (π, years)
0 (%)1 (%)2 (%)3 or More (%)
Norwood (n = 678)
 Era 5 (11.2, 2004–2008)15 (5.6)167 (62.3)71 (26.5)15 (5.6)
 Era 6 (16.1, 2009–2014)7 (3.8)101 (54.3)56 (30.1)22 (11.8)
 Era 7 (10.8, 2015–2018)0 (0.0)70 (58.3)41 (34.20)9 (7.5)
 Era 8 (11.5, 2019–2022)3 (2.9)37 (35.6)55 (52.9)9 (8.6)
 Eras 5–8 (12.5, 2004–2022)
Hybrid (n = 82)
 Era 5 (28.6, 2004–2008)0 (0.0)1 (14.3)4 (57.1)2 (28.6)
 Era 6 (31.2, 2009–2014)0 (0.0)3 (18.8)11 (68.8)2 (12.5)
 Era 7 (46.7, 2015–2018)0 (0.0)6 (40.0)2 (13.3)7 (46.7)
 Era 8 (27.9, 2019–2022)0 (0.0)8 (18.2)26 (59.1)10 (22.7)
 Eras 5–8 (32.1, 2004–2022)
Number of risk factors
Surgical procedure
Era (π, years)
0 (%)1 (%)2 (%)3 or More (%)
Norwood (n = 678)
 Era 5 (11.2, 2004–2008)15 (5.6)167 (62.3)71 (26.5)15 (5.6)
 Era 6 (16.1, 2009–2014)7 (3.8)101 (54.3)56 (30.1)22 (11.8)
 Era 7 (10.8, 2015–2018)0 (0.0)70 (58.3)41 (34.20)9 (7.5)
 Era 8 (11.5, 2019–2022)3 (2.9)37 (35.6)55 (52.9)9 (8.6)
 Eras 5–8 (12.5, 2004–2022)
Hybrid (n = 82)
 Era 5 (28.6, 2004–2008)0 (0.0)1 (14.3)4 (57.1)2 (28.6)
 Era 6 (31.2, 2009–2014)0 (0.0)3 (18.8)11 (68.8)2 (12.5)
 Era 7 (46.7, 2015–2018)0 (0.0)6 (40.0)2 (13.3)7 (46.7)
 Era 8 (27.9, 2019–2022)0 (0.0)8 (18.2)26 (59.1)10 (22.7)
 Eras 5–8 (32.1, 2004–2022)

For purposes of this analysis, risk factors were presence of anomalous pulmonary venous drainage, moderate to severe atrioventricular valve regurgitation, confirmed/suspected genetical anomaly, intact/highly restrictive atrial septum, preterm birth (dichotomized at 37 weeks) and weight at stage 1 reconstruction (dichotomized at 2.5 kg).

Table 4:

Morality rate and number of risk factors by eras and surgical procedure (n = 760)

Number of risk factors
Surgical procedure
Era (π, years)
0 (%)1 (%)2 (%)3 or More (%)
Norwood (n = 678)
 Era 5 (11.2, 2004–2008)15 (5.6)167 (62.3)71 (26.5)15 (5.6)
 Era 6 (16.1, 2009–2014)7 (3.8)101 (54.3)56 (30.1)22 (11.8)
 Era 7 (10.8, 2015–2018)0 (0.0)70 (58.3)41 (34.20)9 (7.5)
 Era 8 (11.5, 2019–2022)3 (2.9)37 (35.6)55 (52.9)9 (8.6)
 Eras 5–8 (12.5, 2004–2022)
Hybrid (n = 82)
 Era 5 (28.6, 2004–2008)0 (0.0)1 (14.3)4 (57.1)2 (28.6)
 Era 6 (31.2, 2009–2014)0 (0.0)3 (18.8)11 (68.8)2 (12.5)
 Era 7 (46.7, 2015–2018)0 (0.0)6 (40.0)2 (13.3)7 (46.7)
 Era 8 (27.9, 2019–2022)0 (0.0)8 (18.2)26 (59.1)10 (22.7)
 Eras 5–8 (32.1, 2004–2022)
Number of risk factors
Surgical procedure
Era (π, years)
0 (%)1 (%)2 (%)3 or More (%)
Norwood (n = 678)
 Era 5 (11.2, 2004–2008)15 (5.6)167 (62.3)71 (26.5)15 (5.6)
 Era 6 (16.1, 2009–2014)7 (3.8)101 (54.3)56 (30.1)22 (11.8)
 Era 7 (10.8, 2015–2018)0 (0.0)70 (58.3)41 (34.20)9 (7.5)
 Era 8 (11.5, 2019–2022)3 (2.9)37 (35.6)55 (52.9)9 (8.6)
 Eras 5–8 (12.5, 2004–2022)
Hybrid (n = 82)
 Era 5 (28.6, 2004–2008)0 (0.0)1 (14.3)4 (57.1)2 (28.6)
 Era 6 (31.2, 2009–2014)0 (0.0)3 (18.8)11 (68.8)2 (12.5)
 Era 7 (46.7, 2015–2018)0 (0.0)6 (40.0)2 (13.3)7 (46.7)
 Era 8 (27.9, 2019–2022)0 (0.0)8 (18.2)26 (59.1)10 (22.7)
 Eras 5–8 (32.1, 2004–2022)

For purposes of this analysis, risk factors were presence of anomalous pulmonary venous drainage, moderate to severe atrioventricular valve regurgitation, confirmed/suspected genetical anomaly, intact/highly restrictive atrial septum, preterm birth (dichotomized at 37 weeks) and weight at stage 1 reconstruction (dichotomized at 2.5 kg).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close